A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension

Clinical trial NCT06647745 · RECRUITING

Trial details

NCT number: NCT06647745
Sponsor: THPharm Corp.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Hypertension

Start date: 2025-04-10
Primary completion: 2026-06-01
Enrollment: 221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.